What is Canagliflozin?

Category: Prescription Drugs

Most popular types: Invokana

false

Canagliflozin is an oral antidiabetic medication that is designed to be used alongside diet and exercise to help improve glycemic control in adults with type 2 diabetes. This agent exerts its effect by regulating the amount of sugar that the body excretes in the urine.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 3
Moderate 6
Mild 3
None 19

Commonly reported side effects and conditions associated with Canagliflozin

Side effect Patients Percentage
Aggressive behavior 1
Candida (fungal) infection 1
Decreased kidney function 1
Diarrhea 1
Excessive thirst (polydipsia) 1
Frequent urination 1

Show all 13 reported side effects

Dosages

Based on patients currently taking Canagliflozin

Dosage Patients Percentage
300 mg daily 2

Why patients stopped taking Canagliflozin

Multiple reasons could be selected

Reason Patients Percentage
Side effects too severe 8
Doctor's advice 4
Other 3
Expense 1
See all 14 patients who've stopped taking Canagliflozin

Duration

Currently taking Canagliflozin

Duration Patients Percentage
1 - 6 months 1
5 - 10 years 1

Stopped taking Canagliflozin

Duration Patients Percentage
Less than 1 month 2
1 - 6 months 1
6 months - 1 year 2
1 - 2 years 5
2 - 5 years 3
Adherence
Adherence Evaluations Percentage
Always 27
Usually 2
Sometimes 0
Never taken as prescribed 2
Burden
Burden Evaluations Percentage
Very hard to take 3
Somewhat hard to take 1
A little hard to take 1
Not at all hard to take 26
Cost per month
Cost per month Evaluations Percentage
$200+ 0
$100-199 1
$50-99 3
$25-49 4
< $25 10
Not specified 13

What people switch to and from

Patients started taking Canagliflozin after stopping:

Treatment Patients Percentage
Metformin (Metformin ER) 3
Sitagliptin (Januvia) 3
Pioglitazone (Actos) 2
Canagliflozin-metformin (Invokamet) 1
Dapagliflozin (Farxiga) 1

Show all 7 treatments patients report switching from

Patients stopped taking Canagliflozin and switched to:

Treatment Patients Percentage
Empaglifozin (Jardiance) 9
Alogliptin (Nesina) 1
Dapagliflozin (Farxiga) 1
Ertugliflozin (Steglatro) 1
insulin detemir (Levemir) 1

Show all 7 treatments patients report switching to

Last updated:
There are no evaluations for Canagliflozin.